WO2018056431A1 - Procédé de mesure de l-kynurénine et kit de mesure - Google Patents

Procédé de mesure de l-kynurénine et kit de mesure Download PDF

Info

Publication number
WO2018056431A1
WO2018056431A1 PCT/JP2017/034439 JP2017034439W WO2018056431A1 WO 2018056431 A1 WO2018056431 A1 WO 2018056431A1 JP 2017034439 W JP2017034439 W JP 2017034439W WO 2018056431 A1 WO2018056431 A1 WO 2018056431A1
Authority
WO
WIPO (PCT)
Prior art keywords
kynurenine
enzyme
reaction
concentration
substance
Prior art date
Application number
PCT/JP2017/034439
Other languages
English (en)
Japanese (ja)
Inventor
宮本　浩士
史直 小林
Original Assignee
池田食研株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 池田食研株式会社 filed Critical 池田食研株式会社
Priority to JP2018540334A priority Critical patent/JP6913956B2/ja
Publication of WO2018056431A1 publication Critical patent/WO2018056431A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/59—Transmissivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Definitions

  • the present invention relates to a method and kit for measuring L-kynurenine using an enzyme.
  • L-kynurenine is known to exist in vivo as a metabolite of L-tryptophan, and various measurement significances have been studied in the medical field. L-kynurenine is generally measured by liquid chromatography, but this measurement is complicated and lacks versatility. As other measurement methods, an antibody method, a colorimetric method using an Ehrlich reagent and an enzyme method are known, but the antibody method is complicated and the colorimetric method has low specificity. As an enzymatic method, a measurement method for detecting fluorescence using kynureninease or kynurenine aminotransferase is known (Non-patent Documents 1 and 2), but biochemical automatic analysis generally used in clinical laboratory settings. There is a problem that the device cannot be used.
  • the enzymatic method using kynureninase is a technique in which a liquid obtained by extracting an enzyme reaction solution with ethyl acetate is measured by a fluorescence method, and there is a problem that it is very complicated.
  • Non-patent Documents 3 to 7 Pseudomonas-derived, human-derived, rat-derived, mosquito or yeast-derived enzymes are known as kynurenine 3-monooxygenase using L-kynurenine as a substrate.
  • kynurenine 3-monooxygenase can be used for the measurement of L-kynurenine.
  • An object of the present invention is to provide a measurement method and a measurement kit that can measure L-kynurenine simply and accurately by using an enzyme.
  • the present inventors have examined a method for measuring kynurenine using an enzyme, and as a result, kynurenine 3-mono in the presence of an electron donor selected from the group consisting of L-kynurenine and NADH, NADPH and derivatives thereof.
  • an electron donor selected from the group consisting of L-kynurenine and NADH, NADPH and derivatives thereof.
  • By reacting oxygenase and measuring the product by adding a metal indicator specific for a divalent copper compound and a monovalent copper ion, or a redox coloring reagent and a charge carrier it is simple, accurate and sensitive.
  • the inventors have found a method capable of quantifying L-kynurenine and have reached the present invention.
  • the present invention provides the following [1] to [19].
  • [1] A sample containing L-kynurenine is subjected to an enzyme reaction with kynurenine 3-monooxygenase in the presence of an electron donor selected from the group consisting of NADH, NADPH and derivatives thereof, and the remaining electrons
  • the enzyme reaction solution in step (B) (1) a step of reacting a divalent copper compound and a metal indicator specific for a monovalent copper ion, or (2) a redox coloring reagent and a charge carrier
  • C Based on the value obtained by subtracting the concentration of the chromogenic substance in the sample not containing L-kynurenine or the sample not containing kynurenine 3-monooxygenase from the concentration of the chromogenic substance obtained in step (B).
  • a method for measuring the amount of L-kynurenine in a sample comprising the step of determining the amount of kynurenine.
  • the chromogenic material obtained in (1) of the step (B) contains a monovalent copper ion produced by the reaction of 3-hydroxykynurenine and a divalent copper compound, and a metal that specifically acts on the ion.
  • the measurement method according to [1] which is produced by a reaction with an indicator.
  • the measuring method as described in. [11] The measuring method according to [10] above, wherein the reducing substance is bilirubin, ascorbic acid and / or uric acid.
  • the reducing substance is bilirubin, ascorbic acid and / or uric acid.
  • at least one selected from the group consisting of tryptophanase, tryptophan oxidase, bilirubin oxidase, ascorbate oxidase, uricase, peroxidase, catalase and hydrogen peroxide contains L-kynurenine
  • L-kynurenine measurement comprising an electron donor selected from the group consisting of NADH, NADPH and derivatives thereof, kynurenine 3-monooxygenase, a divalent copper compound, and a metal indicator specific for monovalent copper ion
  • kit for measuring L-kynurenine, comprising an electron donor selected from the group consisting of NADH, NADPH and derivatives thereof, kynurenine 3-monooxygenase, a redox coloring reagent, and a charge carrier.
  • kits for measuring L-kynurenine wherein the kit according to [17] above further comprises an enzyme that acts on a phenol compound.
  • kit for measuring L-kynurenine wherein the kit according to [18] above further comprises NADH or NADPH regenerating enzyme and a substrate thereof.
  • L-kynurenine can be quantified simply, accurately and with high sensitivity. Since a low concentration of L-kynurenine can be measured, a trace amount of L-kynurenine contained in a living body can be measured.
  • This method can be measured by absorbance, and can be used for bioanalytical automatic analyzers that are currently widely used. Therefore, this method is suitable for measuring a large number of samples, and can be put to practical use in the field of clinical tests.
  • the absorbance at 480 nm derived from the chromogenic material produced by reacting with L-Kyn was measured in a sample that did not contain L-Kyn (control). It is the figure which showed the result of having plotted the difference with the light absorbency of 480 nm originating as OD480.
  • the absorbance at 440 nm derived from the generated chromogenic material does not contain L-Kyn.
  • FIG. 6 is a diagram showing the result of plotting the difference from the absorbance at 440 nm derived from a sample not containing L-Kyn (control) as OD440.
  • P-KMO and NADH react with L-Kyn to obtain an enzyme reaction solution, then act on laccase, and then use WST-1 and diaphorase to determine the absorbance at 440 nm derived from the generated color substance.
  • FIG. 6 is a diagram showing the result of plotting the difference from the absorbance at 440 nm derived from a sample not containing L-Kyn (control) as OD440.
  • P-KMO and NADH react with L-Kyn to obtain an enzyme reaction solution, then act on bilirubin oxidase, and then use WST-1 and diaphorase to determine the absorbance at 440 nm derived from the generated color substance.
  • FIG. 5 is a graph showing the result of plotting the difference from the absorbance at 440 nm derived from a specimen (control) not containing L-Kyn as OD440.
  • P-KMO and NADH are used to react with L-Kyn to obtain an enzyme reaction solution, which is then reacted with peroxidase, alcohol dehydrogenase, ethanol, WST-1 and diaphorase to produce 440 nm derived from the generated color substance. It is the figure which showed the result of having calculated the variation
  • FIG. 7 is a graph showing the result of plotting the difference from the absorbance at 480 nm derived from a specimen not containing ⁇ Kyn (control) as OD480.
  • Reacting with L-Kyn using P-KMO and NADH in the presence of serum to obtain an enzyme reaction solution, allowing POD to act, and then using a surfactant, WST-1 and diaphorase 4 is a graph showing the result of plotting the difference between the absorbance at 440 nm derived from the 440 nm derived from the specimen not containing L-Kyn (control) as OD440.
  • the present invention (A) A sample containing L-kynurenine is subjected to an enzymatic reaction with kynurenine 3-monooxygenase in the presence of an electron donor selected from the group consisting of NADH, NADPH and derivatives thereof, and the remaining electron donor, And obtaining an enzyme reaction solution containing the produced 3-hydroxykynurenine, (B) In the enzyme reaction solution of step (A), (1) a metal indicator specific to a divalent copper compound and a monovalent copper ion, or (2) a step of reacting a redox coloring reagent and a charge carrier, and (C) the color obtained in step (B).
  • the present invention relates to a method for measuring the amount of L-kynurenine.
  • the present invention includes a step (A) of reacting a sample containing L-kynurenine with an electron donor selected from the group consisting of NADH, NADPH and derivatives thereof and kynurenine 3-monooxygenase.
  • sample used in the present invention is not particularly limited as long as it may contain L-kynurenine.
  • biological samples of mammals including humans such as blood (serum, plasma), saliva, urine, cerebrospinal cord Liquid and the like.
  • blood is preferable, and when blood is used as a sample, it is more preferable to use serum or deproteinized blood.
  • the measurement of a biological sample may include a pretreatment step of removing at least one of a reducing substance, a contaminating protein, a metal ion and the like that may interfere with the measurement by a known method.
  • a reducing substance include bilirubin, ascorbic acid, uric acid and the like.
  • examples include bilirubin oxidase for reducing bilirubin, ascorbate oxidase for reducing ascorbic acid, and pretreatment using an enzyme such as uricase for reducing uric acid.
  • treatment with hydrogen peroxide or peroxidase can also be performed. Catalase can also be used to reduce the hydrogen peroxide used or produced.
  • the usage-amount of enzyme, reaction pH, and temperature can be suitably set based on the optimal pH and temperature of each enzyme.
  • the amount of the enzyme used is, for example, 0.1 to 1000 U / mL, preferably 0.5 to 100 U / mL, in the pretreatment solution.
  • the reaction temperature is, for example, 15 to 50 ° C., preferably 20 to 45 ° C., more preferably 25 to 40 ° C.
  • the reaction pH is, for example, 5.0 to 11.0, preferably 5.5 to 10.5, and more preferably 6.0 to 10.0.
  • the reaction time is, for example, 1 to 60 minutes, preferably 1 to 40 minutes.
  • Contaminating protein can be reduced with a deproteinizing agent such as perchloric acid or trichloroacetic acid. After the treatment, neutralization using potassium carbonate or the like can be used as a sample. It should be noted that reducing substances such as bilirubin and hemoglobin can be reduced by the protein removal treatment.
  • a deproteinizing agent such as perchloric acid or trichloroacetic acid.
  • neutralization using potassium carbonate or the like can be used as a sample. It should be noted that reducing substances such as bilirubin and hemoglobin can be reduced by the protein removal treatment.
  • Metal ions can be reduced, for example, with a metal chelator.
  • the metal chelating agent is not particularly limited, but EDTA (ethylenediaminetetraacetic acid), bicine (N, N-bis (2-hydroxyethyl) glycine), DTPA (diethylenetriaminepentaacetic acid), CyDTA (trans-1,2-diaminocyclohexane- N, N, N, N-tetraacetic acid) and the like are preferably used.
  • concentration of a metal chelating agent can be set suitably.
  • the molar concentration is the same or lower than that of the divalent copper compound to be used, more preferably 1/2 or lower.
  • Magnesium ions and the like can be reduced by adding phosphoric acid.
  • a redox agent such as potassium ferricyanide, potassium ferrocyanide, benzoic acid, iodate or nitrite, or adding a surfactant Is mentioned.
  • a surfactant include nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants, such as polyoxyethylene alkyl ethers and polyoxyethylene alkyls.
  • Nonionic surfactants such as phenyl ether, polyoxyethylene sorbitan fatty acid ester, olefin sulfonic acid, polyoxyethylene alkyl phenyl ether sulfate, polyoxyethylene alkyl phenyl ether acetate, sodium lauryl sulfate, sodium cholate, octanoic acid
  • Anionic surfactants such as sodium and sodium dodecylbenzenesulfonate are preferably used.
  • polyoxyethylene sorbitan monolaurate, polyoxyethylene lauryl ether or polyoxyethylene octyl phenyl ether is more preferred, and the average added mole number of EO (ethylene oxide) is preferably 10 to 30, more preferably 5 to 25. It is.
  • polyoxyethylene (20) sorbitan monolaurate, polyoxyethylene (23) lauryl ether or polyoxyethylene (10) octylphenyl ether is preferably used.
  • the surfactant is preferably added in an amount of 0.01 to 5.0% (w / v) with respect to the entire measurement system, and an amount of 0.1 to 2.0% (w / v). It is more preferable to add.
  • the addition time is not particularly limited as long as a series of enzyme reactions proceeds, but it is preferably added before the color development reaction.
  • the liquid subjected to the above pretreatment may be used for measurement immediately after the pretreatment, or may be used after storage in refrigeration or freezing. Moreover, this pre-processing can be implemented at the suitable time before a process (A) and / or a process (B).
  • the L-kynurenine measuring method of the present invention In order to perform the L-kynurenine measuring method of the present invention more accurately, it is preferable to substantially eliminate the influence of contaminants in the sample. For example, since the L-tryptophan concentration in a biological sample is generally considered to be about 10 to 100 times higher than the L-kynurenine concentration, it is preferable to suppress the influence of L-tryptophan on the measurement of L-kynurenine. An L-kynurenine measurement method using NADH as an electron donor is preferable, and a measurement method using NADH alone is more preferable.
  • an L-kynurenine measurement method including a step of reducing L-tryptophan in a sample with an enzyme that acts on L-tryptophan is preferable. This step is preferably performed as a pretreatment prior to the reaction with kynurenine 3-monooxygenase.
  • the enzyme that acts on L-tryptophan is not particularly limited as long as it does not substantially act on L-kynurenine, and examples thereof include tryptophan oxidase and tryptophanase. Tryptophan oxidase is preferably used in combination with catalase.
  • the amount of enzyme used is not particularly limited as long as L-tryptophan can be reduced.
  • the concentration in the pretreatment solution is preferably about 0.1 to 100 U / mL, and about 1 to 10 U / mL. It is more preferable.
  • the concentration in the pretreatment solution is preferably about 0.1 to 10,000 U / mL, more preferably about 1 to 1,000 U / mL.
  • the concentration in the pretreatment solution is preferably about 0.01 to 10 U / mL, and more preferably about 0.1 to 2 U / mL.
  • the reaction temperature, reaction pH, and reaction time can be appropriately set based on the optimum pH and temperature of each enzyme.
  • the reaction temperature is, for example, 15 to 50 ° C., preferably 20 to 45 ° C., more preferably 25 to 40 ° C.
  • the reaction pH is, for example, 5.0 to 11.0, more preferably 5.5 to 10.5, and more preferably 6.0 to 10.0.
  • the reaction time is, for example, 1 to 60 minutes, preferably 1 to 40 minutes.
  • KMO kynurenine 3-monooxygenase
  • a known enzyme derived from a prokaryotic organism such as Pseudomonas or a eukaryotic organism such as human, rat, mosquito or yeast
  • the enzyme used may be a recombinant enzyme or a synthesized enzyme.
  • This enzyme is preferably a soluble enzyme, but a surfactant may be combined with the insoluble enzyme, or an enzyme in which the insoluble enzyme is solubilized by fusion with a solubilized protein or deletion of a membrane-bound portion may be used.
  • an enzyme having a known amino acid sequence can be used.
  • an enzyme having the sequence shown in SEQ ID NO: 1, 2, 3, 4 or 5 can be used. Further, it may be a modified enzyme having kynurenine 3-monooxygenase activity by substituting, adding or deleting one or several amino acids in the sequence shown in SEQ ID NO: 1, 2, 3, 4 or 5. Having a sequence having similarity or identity of SEQ ID NO: 1, 2, 3, 4 or 5, for example 60%, 65%, 70%, 75%, 80%, 85%, 90% or 95% or more, A protein having kynurenine 3-monooxygenase activity may be used.
  • Step (A) of the present invention is carried out in the presence of an electron donor selected from the group consisting of NADH, NADPH and derivatives thereof.
  • NADH or a NADPH derivative can be used to improve the stability of NADH or NADPH, increase the molar extinction coefficient, or the like.
  • the type of NADH or NADPH derivative is not particularly limited as long as the reaction with kynurenine 3-monooxygenase proceeds.
  • a known NADH or NADPH derivative disclosed in JP2012-224638A is known. Things can be used.
  • the amount of enzyme in the enzyme reaction used in the step (A) is not particularly limited as long as L-kynurenine in the sample can be converted to 3-hydroxykynurenine, but is preferably about 0.0001 to 100 U per sample. About 001 to 10 U is more preferable.
  • the concentration of the electron donor in step (A) is not particularly limited as long as L-kynurenine in the sample can be measured, but is preferably 0.01 to 1 mM, more preferably 0.01 to 0.5 mM.
  • the reaction temperature, reaction pH, and reaction time in the step (A) can be appropriately set based on the optimum pH and temperature of the enzyme.
  • the reaction temperature is, for example, 15 to 50 ° C., preferably 20 to 45 ° C., more preferably 25 to 40 ° C.
  • the reaction pH is, for example, 5.0 to 11.0, preferably 5.5 to 10.5, and more preferably 6.0 to 10.0.
  • the reaction time is, for example, 1 to 60 minutes, preferably 1 to 30 minutes, more preferably 1 to 10 minutes.
  • step (B) The present invention provides the product of step (A) (1) a step (B) of reacting a divalent copper compound and a metal indicator specific to a monovalent copper ion, or (2) a redox coloring reagent and a charge carrier.
  • a divalent copper compound is used, and a plurality of moles of monovalent copper ions per mole of 3-hydroxykynurenine can be generated by an oxidation-reduction reaction with 3-hydroxykynurenine in the reaction solution. it can. Furthermore, a coloring substance can be produced by reaction with a metal indicator specific for monovalent copper ions.
  • a water-soluble thing is preferable, for example, copper (II) chloride, copper sulfate (II), copper nitrate (II), copper acetate (II), copper citrate (II) ), Copper (II) gluconate and the like are used. Of these, copper (II) chloride or copper (II) sulfate is preferably used.
  • the metal indicator specific to the monovalent copper ion is not particularly limited, but it does not substantially react with other metal ions and specifically reacts with the monovalent copper ion to form a colored complex. Etc. are used.
  • bathocuproin, neocuproin, bicinchoninic acid, derivatives thereof or salts thereof are preferably used. Of these, bathocuproin or a salt thereof is preferable, and disodium bathocuproin disulfonate is more preferable.
  • the concentration of each reagent in the reaction is preferably 0.01 to 2.0 mM, more preferably 0.02 to 1.0 mM in the case of a divalent copper compound.
  • the metal indicator specific for monovalent copper ions is preferably from 0.01 to 2.0 mM, more preferably from 0.02 to 1.0 mM.
  • the pH during measurement is preferably from 3.0 to 11.0, more preferably from 4.0 to 10.0.
  • the reaction temperature is preferably 15 to 50 ° C, more preferably 20 to 45 ° C, still more preferably 25 to 40 ° C.
  • the metal indicator is preferably added to the sample before adding the divalent copper compound so that the production of monovalent copper ions can be discriminated.
  • the produced monovalent copper ions can be accurately quantified by the change in the monovalent copper ion concentration before and after adding the divalent copper compound.
  • the reducing coloring reagent is an electron selected from the group consisting of NADH, NADPH and derivatives thereof in the reaction solution in the presence of a charge carrier.
  • a reduced coloring material is generated from an oxidized colorless material.
  • the type of reducing coloring reagent is not particularly limited as long as L-kynurenine in a sample can be measured.
  • the concentration in the reaction solution is preferably 0.02 mg / mL or more, more preferably 0.1 mg / mL or more, when a coloring reagent having low solubility in water such as MTT is used or when a high concentration is used.
  • a coloring reagent having low solubility in water such as MTT
  • a high concentration is used.
  • a surfactant such as sodium dodecyl sulfate (SDS) or dimethyl sulfoxide (DMSO) or an organic solvent may be used for solubilization.
  • an oxidizing coloring reagent reacts with an electron donor selected from the group consisting of NADH, NADPH and derivatives thereof in the reaction solution in the presence of a charge carrier.
  • a reduced colorless substance is produced from an oxidized color developing substance.
  • the type of this reagent is not particularly limited as long as L-kynurenine in a sample can be measured, and examples thereof include dichloroindophenol (DCIP).
  • the charge carrier is not particularly limited as long as L-kynurenine in a sample can be measured, but 3-hydroxykynurenine can be reversed without catalyzing the production of a coloring substance by 3-hydroxykynurenine in a reaction solution and a redox coloring reagent. Therefore, it is desirable to inhibit the generation of a color developing substance by the reaction between the electron donor and the redox coloring reagent.
  • the use of diaphorase is preferable. When diaphorase is used, the amount used is preferably 0.01 U / mL or more, more preferably 0.1 U / mL or more, in the reaction solution.
  • the type of diaphorase is not limited as long as it reacts with an electron donor. For example, EC number 1.6.5.2, EC number 1.6.99.1, EC number 1.6.99. Those classified into 3 can be used.
  • the reaction temperature, reaction pH, and reaction time in step (B) can be appropriately set based on the optimum pH and temperature of the enzyme and the like in the first and second aspects.
  • the reaction temperature is, for example, 15 to 50 ° C., preferably 20 to 45 ° C., more preferably 25 to 40 ° C. In addition, you may make it the same temperature in a process (A).
  • the reaction pH is not particularly limited, but for example, pH 3.0 to 12.0 is preferable. In the first embodiment, pH 4.0 to 11.0 is more preferable. In the second embodiment, for example, when diaphorase is used as the charge carrier, pH 6.0 to 10.0 is preferable, and pH 7.0 to 9.0 is more preferable.
  • the reaction pH in step (A) may be the same.
  • the reaction time is, for example, 1 to 60 minutes, preferably 1 to 40 minutes, more preferably 1 to 10 minutes.
  • the type of the buffer solution in the first and second aspects is not particularly limited as long as it has a buffering ability at a target pH.
  • bicine, tris, citric acid In the case of a substance that forms a complex with a copper ion, etc., it is necessary to use it with caution because it may inhibit color development in the first embodiment.
  • the present invention is based on a value obtained by subtracting the concentration of the coloring substance in the sample not containing L-kynurenine or the sample not added with kynurenine 3-monooxygenase from the concentration of the coloring substance obtained in step (B).
  • a step (C) of determining an amount of L-kynurenine Samples that do not contain L-kynurenine or samples without kynurenine 3-monooxygenase are called controls, and exclude the influence on assay values when L-kynurenine or kynurenine 3-monooxygenase is not added. is there.
  • the color-developing substance to be measured in the first aspect is a substance produced by a reaction between a monovalent copper ion and a metal indicator specific to the monovalent copper ion.
  • concentration of this coloring substance By measuring the concentration of this coloring substance, the concentration of monovalent copper ions can be measured, and as a result, the concentration of L-kynurenine in the sample can be measured with high sensitivity.
  • the color-developing substance to be measured in the second aspect is obtained from an oxidation-reduction color-developing reagent, and is an electron selected from the group consisting of NADH, NADPH and their derivatives in the reaction solution in the presence of a charge carrier.
  • a donor is obtained by reacting with a redox coloring reagent.
  • the L-kynurenine concentration can be measured by the following procedure. a) Concentration of the coloring substance obtained by adding the electron donor and kynurenine 3-monooxygenase to the reaction solution not containing L-kynurenine, and further donating a charge carrier and a redox coloring reagent. Measure. Alternatively, after adding an electron donor to a reaction solution containing L-kynurenine, no kynurenine 3-monooxygenase is added, and the concentration of the coloring substance obtained by donating the charge carrier and the redox coloring reagent is adjusted. taking measurement.
  • the concentration of the coloring substance obtained by the reaction of the electron donor with the reducing coloring reagent in the presence of a charge carrier increases depending on the concentration of the electron donor.
  • the reaction with L-kynurenine 3-monooxygenase is carried out, the number of electron donors in the reaction solution is the same as the number of moles of L-kynurenine, so in the enzyme reaction solution after the reaction with kynurenine 3-monooxygenase, The chromogenic substance decreases depending on the concentration of L-kynurenine, but the absolute value of the slope is considered to be equal to the absolute value of the slope obtained between the electron donor and the chromogenic substance.
  • the decrease in the concentration of the chromogenic substance accompanying the increase in the L-kynurenine concentration is not only due to the influence of the decrease in the electron donor after the reaction by the kynurenine 3-monooxygenase, but also increases as the L-kynurenine concentration increases. Since the influence of the amount of hydroxykynurenine was also taken into account, it was found that an increase in absolute value of the slope more than expected was obtained. As a result, by measuring the concentration of the coloring material, the concentration of L-kynurenine in the sample can be measured with high sensitivity.
  • a substance that acts on 3-hydroxykynurenine is added, whereby the electron donor and the redox coloring by the charge carrier are added. It has been found that the effect of inhibiting the reaction with the reagent is further increased, and as a result, a more sensitive measurement can be performed.
  • the specific substance is not particularly limited as long as it does not inhibit the reaction in a system that does not contain 3-hydroxykynurenine, but is not particularly limited as long as it is a substance that inhibits the reaction in a system that contains 3-hydroxykynurenine.
  • oxidizing agent or a polymerization agent that acts, and more preferably an enzyme that acts on a phenolic compound.
  • peroxidase EC number 1.11.1.X
  • laccase EC number 1.10.3.2
  • bilirubin oxidase EC number 1.3.3.5
  • Tyrosinase EC number 1.10.3.1 or 1.14.18.1
  • 3-hydroxyanthranilate oxidase EC number 1.10.3.5
  • ferrooxidase EC number 1.16.3) .1
  • phenol-2-monooxygenase EC number 1.14.13.7 or 1.14.14.20
  • aminophenol oxidase EC number 1.10.3.4
  • glyxazone synthase EC number 1.10.3.15
  • 2-aminophenol 1,6-dioxygenase EC number 1.13.11.74
  • 2-amino-5-chlorophenol 1 6-dioxygenase EC number 1.13.1.11.76
  • peroxidase, laccase or bilirubin oxidase is preferable.
  • concentration of peroxidase, laccase or bilirubin oxidase hardly inhibits the reaction in a system not containing 3-hydroxykynurenine, but the range is not limited as long as it is a concentration that inhibits the reaction in a system containing 3-hydroxykynurenine.
  • it is preferably 0.001 to 1,000 U / mL, more preferably 0.01 to 100 U / mL.
  • the reaction pH, temperature, and time can be appropriately set in accordance with the aforementioned color development reaction and conditions suitable for each enzyme.
  • the timing of addition of the enzyme acting on the phenolic compound may be any time before, during or after the reaction with kynurenine 3-monooxygenase, but preferably after the reaction with kynurenine 3-monooxygenase.
  • the reaction temperature is, for example, 15 to 50 ° C., preferably 20 to 45 ° C., more preferably 25 to 40 ° C.
  • the reaction pH is, for example, 5.0 to 11.0, preferably 5.5 to 10.5, and more preferably 6.0 to 10.0.
  • the reaction time is, for example, 1 to 60 minutes, preferably 1 to 45 minutes, more preferably 1 to 10 minutes.
  • an enzyme that acts on a phenolic compound can be combined with an enzyme cycling method after or simultaneously with the addition of an enzyme that acts on the phenolic compound, thereby enabling further highly sensitive measurement.
  • This enzyme cycling method specifically refers to NADH or NADPH by donating an appropriate NADH or NADPH regenerating enzyme and its substrate to NAD + or NADP + obtained by a reaction using a charge carrier. In this method, the reaction using charge carriers is performed again.
  • NADH or NADPH regenerating enzyme examples include alcohol dehydrogenase, glucose dehydrogenase, glutamate dehydrogenase, formate dehydrogenase, malate dehydrogenase, glucose-6-phosphate dehydrogenase, and phosphoglucocone.
  • alcohol dehydrogenase examples include alcohol dehydrogenase, glucose dehydrogenase, glutamate dehydrogenase, formate dehydrogenase, malate dehydrogenase, glucose-6-phosphate dehydrogenase, and phosphoglucocone.
  • the type of enzyme or its substrate is not limited as long as the purpose is satisfied.
  • alcohol dehydrogenase and ethanol glucose dehydrogenase and glucose
  • glutamate dehydrogenation Enzyme and glutamate, formate dehydrogenase and formate, malate dehydrogenase and malate, glucose 6-phosphate dehydrogenase and glucose 6-phosphate, phosphogluconate dehydrogenase and phosphogluconate, glycerol dehydrogenase and glycerol Etc. are known.
  • the amount of enzyme is not particularly limited as long as L-kynurenine can be measured in the sample, but the concentration of alcohol dehydrogenase in the reaction solution is about 0.5 to 30 U / mL. It is preferably about 3 to 15 U / mL.
  • reaction temperature, reaction pH, and reaction time can be suitably set based on the optimum pH and temperature of each enzyme.
  • the concentration measuring means for the color developing substance is not particularly limited, and for example, measurement of absorbance change by a spectrophotometer can be exemplified. In the measurement with a spectrophotometer, it is preferable to select appropriately from the rate method or the endpoint method.
  • spectrophotometers used for measurement include commercial products sold by various companies such as JASCO, Hitachi High-Technologies, Shimadzu Corporation.
  • the measurement wavelength in the absorbance measurement varies depending on each metal indicator.
  • absorbance at a wavelength of around 480 nm, neocuproine at around 450 nm, and bicinchoninic acid at around 562 nm can be used. It may be changed.
  • the measurement wavelength for quantifying the generated color substance is not particularly limited as long as each color substance has absorption, but a wavelength indicating the absorption maximum of each color substance is desirable.
  • WST-1 when WST-1 is used, it is preferably 400 to 480 nm, and more preferably measured at a measurement wavelength around 440 nm.
  • the absorbance when measuring at a wavelength that exhibits an absorption maximum with a high NADH or NADPH concentration, the absorbance may be too high and the accuracy may be lost. It is also possible to measure by shifting to either.
  • Optional component In the L-kynurenine measurement method of the present invention, other optional components known to those skilled in the art may be appropriately contained to enhance the stability of the reagent components such as the enzyme.
  • the optional component is not particularly limited as long as it does not affect the measurement.
  • flavin adenine dinucleotide (FAD), bovine serum albumin (BSA), ovalbumin, saccharide, sugar alcohols, carboxyl group-containing compound, antioxidant Examples include agents, surfactants, amino acids having no activity with enzymes, and the like.
  • kynurenine 3-monooxygenase derived from Pseudomonas tends to increase in stability and activity when the salt concentration is high.
  • the final concentration of the buffer solution or sodium chloride of the reagent composition is 10 mM or more. Preferably, it is more preferably 100 mM or more.
  • the measurement of the present invention can be performed using a kit for measuring L-kynurenine containing kynurenine 3-monooxygenase and the electron donor.
  • the kynurenine 3-monooxygenase included in the kit may be an enzyme that converts L-kynurenine into 3-hydroxykynurenine.
  • any enzyme that catalyzes the reaction of producing 3-hydroxykynurenine, the electron acceptor and water in the presence of the electron donor, H + and oxygen using L-kynurenine as a substrate may be used.
  • the kit of the present invention contains at least one selected from the group consisting of tryptophanase, tryptophan oxidase, bilirubin oxidase, ascorbate oxidase, uricase, peroxidase, catalase and hydrogen peroxide for pretreatment. May be.
  • a divalent copper compound is used, and a metal indicator that specifically reacts with monovalent copper ions is included.
  • the redox coloring reagent and the charge carrier are used. That is, in the first aspect, an electron donor selected from the group consisting of NADPH, NADP and derivatives thereof, kynurenine 3-monooxygenase, a divalent copper compound, and a metal indicator specific for a monovalent copper ion are included.
  • L-kynurenine measurement kit is used.
  • an L-kynurenine measurement kit including the electron donor, kynurenine 3-monooxygenase, a redox coloring reagent and a charge carrier is used.
  • the kit in the second aspect may further contain an enzyme that acts on a phenolic compound, and may further contain NADH or NADPH regenerating enzyme and its substrate.
  • Example 1 (Measurement with copper (II) chloride / bathocuproine system) L-kynurenine at each concentration was quantified by measuring the resulting monovalent copper ion using kynurenine 3-monooxygenase (P-KMO) and Pseudomonas (Pseudomonas) -derived copper chloride (II). 2.64 mL of the reagent mixture was placed in a quartz cell having an optical path length of 1 cm and incubated at 25 ° C. for 5 minutes. Then, 0.06 mL of P-KMO was added and mixed, and the enzyme reaction was started at 25 ° C.
  • P-KMO kynurenine 3-monooxygenase
  • Pseudomonas Pseudomonas
  • the composition of the enzyme reaction solution was 100 mM HEPES buffer (pH 7.5), 0.5, 1 or 2 ⁇ M L-kynurenine, 0.05 mM NADH, and 0.01 U / mL P-KMO (Note: reaction)
  • the concentration of the liquid is indicated by the concentration after addition of copper (II) chloride).
  • As a control ultrapure water was used instead of the substrate.
  • P-KMO is a protein having the amino acid sequence described in SEQ ID NO: 1, and is published by UniProt as Q84HF5 (http://www.uniprot.org/uniprot/Q84HF5).
  • Q84HF5 http://www.uniprot.org/uniprot/Q84HF5
  • the blank value was subtracted from each L-kynurenine concentration and the measured value 4 minutes after the control (subtraction value A and subtraction value B). Subsequently, a value obtained by subtracting the control subtraction value B from the subtraction value A of each L-kynurenine concentration was plotted in the figure as OD480. This measurement was performed three times on different days. The measured values and average values are shown in FIG.
  • FIG. 1 shows that the value of OD480 increases with increasing L-kynurenine concentration, indicating that L-kynurenine can be quantified by P-KMO.
  • reproducible data was obtained even when the L-kynurenine concentration was as low as 2 ⁇ M or less, and it was shown that L-kynurenine can be quantified with high sensitivity by P-KMO. It was done.
  • L-kynurenine can be quantified with high sensitivity by using an electron donor such as kynurenine 3-monooxygenase, NADH, disodium bathocuproin disulfonate and copper (II) chloride.
  • an electron donor such as kynurenine 3-monooxygenase, NADH, disodium bathocuproin disulfonate and copper (II) chloride.
  • Example 2 Measurement with diaphorase / WST-1 system (using NADH)
  • the L-kynurenine solution at each concentration was used as a sample, and the amount of NADH decreased by the P-KMO reaction was measured using diaphorase as a charge carrier and WST-1 as a reducing coloring reagent.
  • 1.8 mL of the enzyme reaction solution was added to and mixed with a quartz cell having an optical path length of 1 cm, and the enzyme reaction was carried out at 25 ° C. for 15 minutes.
  • the composition of the enzyme reaction solution was 50 mM potassium phosphate buffer (pH 7.5), 1, 2, 3 or 4 ⁇ M L-kynurenine, 0.03 mM NADH, and 0.2 U / mL P-KMO.
  • As a control ultrapure water was used instead of the substrate (Note: The concentration of the reaction solution is shown by the concentration after addition of diaphorase).
  • FIG. 2 shows the result of plotting the value obtained by subtracting the subtraction value C of each L-kynurenine concentration from the subtraction value D of the control as OD440.
  • FIG. 2 shows that the OD440 value increases with increasing L-kynurenine concentration, indicating that L-kynurenine can be quantified.
  • L-kynurenine can be quantified with high sensitivity by using a reducing coloring reagent such as kynurenine 3-monooxygenase, NADH, diaphorase and WST-1.
  • a reducing coloring reagent such as kynurenine 3-monooxygenase, NADH, diaphorase and WST-1.
  • Example 3 Measurement with diaphorase / WST-1 system (using NADPH)
  • the L-kynurenine solution at each concentration was used as a sample, and the amount of NADPH decreased by the P-KMO reaction was measured using diaphorase as a charge carrier and WST-1 as a reducing coloring reagent.
  • 1.8 mL of the enzyme reaction solution was added to and mixed with a quartz cell having an optical path length of 1 cm, and the enzyme reaction was carried out at 25 ° C. for 15 minutes.
  • the composition of the enzyme reaction solution is 50 mM potassium phosphate buffer (pH 7.5), 0.5, 1 or 2 ⁇ M L-kynurenine, 0.04 mM EDTA, 0.03 mM NADPH, and 0.2 U / mL P-KMO. (Note: The concentration of the reaction solution is indicated by the concentration after addition of diaphorase). As a control, ultrapure water was used instead of the substrate.
  • FIG. 3 shows the result of plotting the value obtained by subtracting the subtracted value C of each L-kynurenine concentration from the subtracted value D of the control as OD440.
  • FIG. 3 shows that the value of OD440 increases with increasing L-kynurenine concentration, indicating that L-kynurenine can be quantified.
  • the slope was an increase of 0.058 [abs] per ⁇ M of L-kynurenine, and even when NADPH was used, the L-kynurenine concentration could be quantified with high sensitivity.
  • Example 4 (Measurement with diaphorase / WST-1 / POD system) Using L-kynurenine solution of each concentration as a sample, after reaction with P-KMO, peroxidase (POD) was mixed, and the reduced NADH amount was reduced using diaphorase as a charge carrier and WST-1 as a reducing coloring reagent. It was measured. 1.85 mL of the enzyme reaction solution was added to and mixed with a quartz cell having an optical path length of 1 cm, and the enzyme reaction was carried out at 25 ° C. for 30 minutes.
  • P-KMO peroxidase
  • the composition of the enzyme reaction solution was 100 mM Tris-HCl buffer (pH 8.5), 0.25, 0.5, 1 or 2 ⁇ M L-kynurenine, 0.1 mM EDTA, 0.03 mM NADH, and 0.2 U / mL P. -KMO (Note: The concentration of the reaction solution is indicated by the concentration after addition of diaphorase). As a control, ultrapure water was used instead of the substrate.
  • FIG. 4 shows the result of plotting the value obtained by subtracting the subtracted value C of each L-kynurenine concentration from the subtracted value D of the control as OD440.
  • concentration of L-kynurenine increased, the value of OD440 increased, indicating that L-kynurenine can be quantified by adding POD.
  • the slope was an increase of 0.2 [abs] per 1 ⁇ M of L-kynurenine, and measurement with higher sensitivity than in Example 2 was possible.
  • Example 5 (Measurement with diaphorase / WST-1 / laccase system) L-kynurenine solutions at various concentrations were used as samples. After reaction with P-KMO, laccase was mixed, and the decreased amount of NADH was measured using diaphorase as a charge carrier and WST-1 as a reducing coloring reagent. 1.84 mL of the enzyme reaction solution was added to and mixed with a quartz cell having an optical path length of 1 cm, and the enzyme reaction was carried out at 25 ° C. for 30 minutes.
  • the composition of the enzyme reaction solution is 100 mM potassium phosphate buffer (pH 7.0), 0.25, 0.5, or 1 ⁇ M L-kynurenine, 0.05 mM EDTA, 0.04 mM NADH, and 0.2 U / mL P. -KMO (Note: The concentration of the reaction solution is indicated by the concentration after addition of diaphorase). As a control, ultrapure water was used instead of the substrate.
  • FIG. 5 shows the result of plotting the value obtained by subtracting the subtracted value C of each L-kynurenine concentration from the subtracted value D of the control as OD440.
  • OD440 Up to 0.5 ⁇ M L-kynurenine, the value of OD440 increased with increasing concentration, indicating that L-kynurenine can be quantified by adding laccase.
  • the slope was an increase of 0.12 [abs] per 1 ⁇ M L-kynurenine, and measurement with higher sensitivity than in Example 2 was possible.
  • Example 6 (Measurement with diaphorase / WST-1 / bilirubin oxidase system) L-kynurenine solution of each concentration was used as a sample. After reaction with P-KMO, bilirubin oxidase was mixed, and the decreased amount of NADH was measured using diaphorase as a charge carrier and WST-1 as a reducing coloring reagent. . 1.84 mL of the enzyme reaction solution was added to and mixed with a quartz cell having an optical path length of 1 cm, and the enzyme reaction was carried out at 25 ° C. for 30 minutes.
  • the composition of the enzyme reaction solution was 100 mM Tris-HCl buffer (pH 8.5), 0.25, 0.5, 1, or 2 ⁇ M L-kynurenine, 0.05 mM EDTA, 0.03 mM NADH, and 0.2 U / mL.
  • P-KMO was used.
  • ultrapure water was used instead of the substrate (Note: The concentration of the reaction solution is shown by the concentration after addition of diaphorase).
  • FIG. 6 shows the result of plotting the value obtained by subtracting the subtracted value C of each L-kynurenine concentration from the subtracted value D of the control as OD440.
  • the OD440 value increased with increasing concentration, indicating that L-kynurenine can be quantified by adding bilirubin oxidase.
  • the slope increased by 0.1 [abs] per 1 ⁇ M L-kynurenine, and higher sensitivity measurement than in Example 2 was possible.
  • Example 7 (Measurement by enzyme cycling method in diaphorase / WST-1 / POD system)
  • the L-kynurenine solution at each concentration was used as a sample, and the reaction with P-KMO was performed with 0.4 mL of the reaction solution A.
  • the composition of the reaction solution A is 100 mM potassium phosphate buffer (pH 7.5), 0.25, 0.5, 0.75, 1 ⁇ M L-kynurenine, 2 mM EDTA, 0.04 mM NADH, and 0.4 U / mL.
  • P-KMO was used.
  • As a control ultrapure water was used instead of the substrate.
  • the reaction was carried out at 25 ° C. for 15 minutes.
  • reaction solution B After completion of the reaction, it was mixed with 1.5 mL of reaction solution B.
  • reaction solution B 200 mM potassium phosphate buffer (pH 7.5), 1 mM EDTA, 4% (v / v) ethanol, 5 U / mL alcohol dehydrogenase (made by Oriental Yeast), 1 U / mL POD, and 0.2 mg / mL WST-1 (Note: The concentration of this reaction solution is shown by the concentration after addition of diaphorase).
  • the final concentration of L-kynurenine at this time is 0.05, 0.1, 0.15, and 0.2 ⁇ M by adding the reaction solution B and the diaphorase solution.
  • the amount of change at 440 nm per minute was calculated from the data from 0 to 4 minutes after the start of enzyme cycling. Subsequently, in order to calculate the amount of change of 440 nm in 4 minutes of enzyme reaction, the result of plotting the value obtained by multiplying the amount of change of 440 nm per minute by 4 as OD440 is shown in FIG. As a result, the value of OD440 increased as the concentration of L-kynurenine increased, and it was shown that L-kynurenine at a low concentration can be quantified by combining the enzyme cycling method.
  • Example 8 Measurement in the copper (II) chloride / vasocproin system in the presence of serum
  • deproteinized serum After adding 0.5N perchloric acid solution to human normal serum and mixing the supernatant by centrifugation, neutralize it by adding 180 ⁇ L of 2N potassium carbonate solution to 1000 ⁇ L of the resulting solution, After refrigerated storage, deproteinized serum was obtained by removing excess potassium perchlorate as a precipitate. 2.445 mL of an enzyme reaction solution containing 1.0 mL of deproteinized serum was added to and mixed with a quartz cell having an optical path length of 1 cm, and a pretreatment was performed to reduce reducing substances at 37 ° C. for 20 minutes.
  • the composition of the enzyme reaction solution was 200 mM HEPES buffer (pH 7.5), 40 ⁇ M EDTA, 1 U / mL ascorbate oxidase (manufactured by Wako Pure Chemical Industries), 0.5 U / mL uricase (manufactured by Wako Pure Chemical Industries), 10 U / It was made into mL catalase (made by Wako Pure Chemical Industries).
  • the mixture was added to 100 ⁇ M NADPH, 0.5, 1, 2 ⁇ M L-kynurenine, 0.08 U / mL P-KMO, and reacted at 30 ° C. for 30 minutes.
  • the enzyme reaction solution at this time was adjusted to 2.55 mL (Note: the concentration of the reaction solution is indicated by the concentration after addition of copper (II) chloride).
  • ultrapure water was used instead of the substrate.
  • the blank value was subtracted from each L-kynurenine concentration and the measured value 10 minutes after the control (subtraction value A and subtraction value B). Subsequently, a value obtained by subtracting the control subtraction value B from the subtraction value A of each L-kynurenine concentration was plotted in the figure as OD480.
  • the OD480 value increased as the L-kynurenine concentration increased, indicating that L-kynurenine can be quantified by this method.
  • L-kynurenine is highly sensitive by pretreatment, using kynurenine 3-monooxygenase, NADH, disodium bathocuproine disulfonate and copper (II) chloride. It was found that it can be quantified.
  • Example 9 Measurement with diaphorase / WST-1 / POD system in the presence of serum
  • the measurement which added polyoxyethylene (20) sorbitan monolaurate (brand name: Tween20) which is surfactant was performed.
  • An enzyme reaction solution (1.5 mL) containing 0.2 mL of human normal serum was added to and mixed with a quartz cell having an optical path length of 1 cm, and an enzyme reaction was performed at 25 ° C. for 10 minutes.
  • the composition of the enzyme reaction solution was 200 mM potassium phosphate buffer (pH 7.5), 0.1, 0.2, 0.3 or 0.5 ⁇ M L-kynurenine, 1 mM EDTA, 0.04 mM NADH, 0.2 U / mL P-KMO, 0.5 U / mL POD.
  • ultrapure water was used instead of the substrate (Note: The concentration of the reaction solution is shown by the concentration after addition of diaphorase).
  • evaluation in a system without addition of serum was also performed.
  • FIG. 9 shows the result of plotting the value obtained by subtracting the subtraction value C of each L-kynurenine concentration from the subtraction value D of the control as OD440.
  • the OD440 value increased as the concentration of L-kynurenine increased, indicating that L-kynurenine can be quantified.
  • the slope increased by about 0.1 [abs] per 0.5 ⁇ M L-kynurenine regardless of the presence of serum, that is, increased by about 0.2 [abs] when converted to 1 ⁇ M L-kynurenine.
  • the result was equivalent to Example 4.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La présente invention concerne un procédé de mesure et un kit de mesure permettant de mesurer de manière pratique, précise et avec une sensibilité élevée, la L-kynurénine. L'invention concerne un procédé et un kit de mesure qui mesurent la teneur en L-kynurénine dans un échantillon, ledit procédé et ledit kit de mesure comprenant : (A) une étape consistant à provoquer une réaction enzymatique entre la kynurénine 3-monooxygénase et un échantillon contenant de la L-kynurénine en présence d'un donneur d'électrons choisi dans le groupe constitué par NADH, NADPH et des dérivés correspondants pour obtenir un liquide de réaction enzymatique comprenant un donneur d'électrons résiduel et de la 3-hydroxykynurénine produite ; (B) une étape consistant à faire réagir (1) un composé à base de cuivre divalent et un indicateur métallique spécifique des ions de cuivre monovalents ou (2) un réactif de coloration redox et un support de charges avec le liquide de réaction enzymatique obtenu à l'étape (A) ; et (C) une étape de détermination de la teneur en L-kynurénine dans l'échantillon sur la base d'une valeur obtenue par soustraction, à la concentration en substance colorante obtenue à l'étape (B), de la concentration en la substance colorante dans un spécimen d'échantillon qui ne contient pas de L-kynurénine ou un spécimen d'échantillon auquel n'a pas été ajoutée la kynurénine 3-monooxygénase.
PCT/JP2017/034439 2016-09-26 2017-09-25 Procédé de mesure de l-kynurénine et kit de mesure WO2018056431A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018540334A JP6913956B2 (ja) 2016-09-26 2017-09-25 Ｌ−キヌレニンの測定方法及び測定キット

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2016186714 2016-09-26
JP2016-186714 2016-09-26
JP2017063852 2017-03-09
JP2017-063852 2017-03-09

Publications (1)

Publication Number Publication Date
WO2018056431A1 true WO2018056431A1 (fr) 2018-03-29

Family

ID=61689945

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/034439 WO2018056431A1 (fr) 2016-09-26 2017-09-25 Procédé de mesure de l-kynurénine et kit de mesure

Country Status (2)

Country Link
JP (1) JP6913956B2 (fr)
WO (1) WO2018056431A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109813918A (zh) * 2019-01-11 2019-05-28 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) 一种总胆红素测定试剂盒
WO2019182008A1 (fr) * 2018-03-21 2019-09-26 池田食研株式会社 Procédé de mesure de 2-aminophénol
WO2023001461A1 (fr) 2021-07-19 2023-01-26 Nchain Licensing Ag Application de conditions sur des transactions de chaîne de blocs
WO2023001460A1 (fr) 2021-07-19 2023-01-26 Nchain Licensing Ag Application de conditions sur des transactions de chaîne de blocs
WO2024017786A1 (fr) 2022-07-22 2024-01-25 Nchain Licensing Ag Fourniture de preuve et vérification de données d'entrée

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4989596A (fr) * 1972-12-25 1974-08-27
JPS63233800A (ja) * 1987-03-20 1988-09-29 Toyo Jozo Co Ltd レシチンコレステロ−ルアシルトランスフエラ−ゼの活性測定法
JPS63248397A (ja) * 1987-04-02 1988-10-14 Toyobo Co Ltd Ｄ−マンノ−スの定量法
JPH06339397A (ja) * 1993-08-30 1994-12-13 Toyobo Co Ltd 生体試料中の還元物質の除去法
JPH1070996A (ja) * 1996-08-29 1998-03-17 Toyo Roshi Kaisha Ltd 酸化還元反応に基づくｐｏｄ様活性物質測定用組成物
JP2004506915A (ja) * 2000-08-18 2004-03-04 ザ　ゼネラル　ホスピタル　コーポレーション 白内障を阻害又は促進する物質を同定する方法及びその使用
JP2009039015A (ja) * 2007-08-07 2009-02-26 Shino Test Corp テトラゾリウム化合物を色原体として用いる試料中の測定対象物質の測定方法及び測定試薬、非特異的発色を抑制する方法、並びに非特異的発色抑制剤
JP2016520827A (ja) * 2013-05-03 2016-07-14 ザリオン ゲーエムベーハー 移植拒絶反応、神経変性疾患又はうつ病と特に関連する潜在的炎症のインビトロ早期検出方法
JP2017063786A (ja) * 2015-09-29 2017-04-06 池田食研株式会社 Ｌ−キヌレニンの測定方法及び測定キット

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4989596A (fr) * 1972-12-25 1974-08-27
JPS63233800A (ja) * 1987-03-20 1988-09-29 Toyo Jozo Co Ltd レシチンコレステロ−ルアシルトランスフエラ−ゼの活性測定法
JPS63248397A (ja) * 1987-04-02 1988-10-14 Toyobo Co Ltd Ｄ−マンノ−スの定量法
JPH06339397A (ja) * 1993-08-30 1994-12-13 Toyobo Co Ltd 生体試料中の還元物質の除去法
JPH1070996A (ja) * 1996-08-29 1998-03-17 Toyo Roshi Kaisha Ltd 酸化還元反応に基づくｐｏｄ様活性物質測定用組成物
JP2004506915A (ja) * 2000-08-18 2004-03-04 ザ　ゼネラル　ホスピタル　コーポレーション 白内障を阻害又は促進する物質を同定する方法及びその使用
JP2009039015A (ja) * 2007-08-07 2009-02-26 Shino Test Corp テトラゾリウム化合物を色原体として用いる試料中の測定対象物質の測定方法及び測定試薬、非特異的発色を抑制する方法、並びに非特異的発色抑制剤
JP2016520827A (ja) * 2013-05-03 2016-07-14 ザリオン ゲーエムベーハー 移植拒絶反応、神経変性疾患又はうつ病と特に関連する潜在的炎症のインビトロ早期検出方法
JP2017063786A (ja) * 2015-09-29 2017-04-06 池田食研株式会社 Ｌ−キヌレニンの測定方法及び測定キット

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
IINUMA, F. ET AL.: "FLUOROMETRIC DETERMINATION OF KYNURENINE DERIVATIVES BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH HYDROGEN PEROXIDE AND SODIUM CARBONATE", CHEMICAL ANALYSIS (BUNSEKI KAGAKU), vol. 33, no. 7, 1 January 1984 (1984-01-01), pages E315 - E322, XP055498892, ISSN: 0525-1931, Retrieved from the Internet <URL:https://doi.org/10.2116/bunsekikagaku.33.7_E315> *
JOSEPH, MH. ET AL.: "The determination of kynurenine in plasma", CLIN. CHIM. ACTA, vol. 63, no. 2, 1 September 1975 (1975-09-01), pages 197 - 204, XP025198987, ISSN: 0009-8981, Retrieved from the Internet <URL:https://doi.org/10.1016/0009-8981(75)90163-1> *
NAITO, J. ET AL.: "Determination of kynurenine in serum by high-performance liquid chromatography after enzymatic conversion to 3-hydroxykynurenine", ANAL. BIOCHEM., vol. 161, no. 1, 15 February 1987 (1987-02-15), pages 16 - 19, XP024819309, ISSN: 0003-2697, Retrieved from the Internet <URL:https://doi.org/10.1016/0003-2697(87)90644-0> *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019182008A1 (fr) * 2018-03-21 2019-09-26 池田食研株式会社 Procédé de mesure de 2-aminophénol
CN109813918A (zh) * 2019-01-11 2019-05-28 河北省医疗器械与药品包装材料检验研究院(河北省医疗器械技术审评中心) 一种总胆红素测定试剂盒
CN109813918B (zh) * 2019-01-11 2021-04-09 河北省药品医疗器械检验研究院 一种总胆红素测定试剂盒
WO2023001461A1 (fr) 2021-07-19 2023-01-26 Nchain Licensing Ag Application de conditions sur des transactions de chaîne de blocs
WO2023001460A1 (fr) 2021-07-19 2023-01-26 Nchain Licensing Ag Application de conditions sur des transactions de chaîne de blocs
WO2024017786A1 (fr) 2022-07-22 2024-01-25 Nchain Licensing Ag Fourniture de preuve et vérification de données d'entrée
WO2024017798A1 (fr) 2022-07-22 2024-01-25 Nchain Licensing Ag Fourniture de preuve et vérification de données d'entrée

Also Published As

Publication number Publication date
JP6913956B2 (ja) 2021-08-04
JPWO2018056431A1 (ja) 2019-07-04

Similar Documents

Publication Publication Date Title
WO2018056431A1 (fr) Procédé de mesure de l-kynurénine et kit de mesure
JP5131955B2 (ja) プロテアーゼ反応促進剤及び／又は色素の安定化剤を含む試薬
KR920001449B1 (ko) 효소적산화에 의한 검체의 비색적 측정방법 및 시약
JP5097758B2 (ja) 酸化還元反応を用いた糖化タンパク質の測定方法および測定キット
US20040063213A1 (en) Assay method with the use of redox reaction
JP4889396B2 (ja) ロイコ色素の安定化方法
JP2009072136A (ja) 還元系色素を用いた安定な測定方法、およびその試薬
JP2017063786A (ja) Ｌ−キヌレニンの測定方法及び測定キット
JPH0739397A (ja) 塩素イオンの定量方法
EP0100217B1 (fr) Procédé pour la détermination quantitative d&#39;un substrat traité avec oxidase
JP4200467B1 (ja) 総分岐鎖アミノ酸測定用液状試薬
US20030186346A1 (en) Process for producing protein decomposition product
JP4143698B2 (ja) Ｎ−（カルボキシメチルアミノカルボニル）−４，４’−ビス（ジメチルアミノ）ジフェニルアミンナトリウムの誤発色防止方法および前記方法を用いた試薬溶液ならびに測定方法
JP4214277B2 (ja) ホルマザンを用いた酸化還元反応による測定方法
MX2007002224A (es) Metodo para determinar la concentracion de analitos en muestras por mediacion directa de enzimas.
Kayamori et al. Enzymatic method for assaying uric acid in serum with a new tetrazolium salt produces water-soluble formazan dye
JP7330516B2 (ja) ２－アミノフェノール類の測定方法
JP3910174B2 (ja) アジ化ナトリウムを用いた測定方法
CN111575339A (zh) 1，5-脱水葡萄糖醇酶学定量方法及其试剂
Racek Lactate biosensor based on human erythrocytes
JPS63116700A (ja) 微量物質の分析方法
US4695540A (en) Quantitative determination of substrate treated with oxidase
Yao et al. Facile chemiluminescence assay for acyl-CoA oxidase activity: fundamentals and illustrative examples
JP2004113138A (ja) ホモシステインの測定方法及び測定用試薬
JPS60221100A (ja) 新規グルタチオン・オキシダ−ゼの使用法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17853198

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2018540334

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17853198

Country of ref document: EP

Kind code of ref document: A1